The Real Deal - TSC

Monsanto Can Help Your Portfolio Grow

 

Some Dark Clouds

Monsanto is not without its risks. Despite the refreshing focus and pragmatism of new CEO Hugh Grant, Monsanto is still associated with a number of controversies. Solutia, which Monsanto spun off in 1997, filed for bankruptcy last year, which could expose Monsanto to some pension and health care liabilities related to certain Solutia employees.

The company is also dealing with litigation involving Delta and Pine Land (DLP), which it unsuccessfully attempted to acquire in 1998. Finally, there probably will be no shortage of headline risk associated with public concern over GMO seeds, especially in Europe. Monsanto did receive some good news on this front in March, though: The European Union safety authority declared Monsanto's Roundup Ready canola safe for human consumption. Then, last month, the EU effectively lifted its ban on GMO foods by approving a modified strain of corn. Monsanto has 11 of the 22 GMO products that are pending approval in the EU.

These risks seem manageable in light of Monsanto's strong cash flow and sturdy balance sheet. Monsanto's debt-to-capital ratio is just 24%. And the company is expected to produce $350 million to $400 million in free cash flow before dividends ($230 million after) in fiscal 2004, marking the fourth straight year that free cash flow has been solidly above $200 million. Free cash flow is likely to be used for share repurchases. The stock also pays a dividend, with a current yield of 1.7%.

Monsanto isn't your typical biotech stock. But its promising pipeline, solid earnings, strong cash flow and relatively attractive valuation make it worth considering.

>To order reprints of this article, click here: Reprints

Odette Galli is a freelance columnist for RealMoney.com. She has been a writer at SmartMoney Magazine and a senior manager at Ark Asset Management, where she co-managed $3 billion in institutional assets. In addition, Galli was a senior vice president at J & W Seligman. At the time of publication, she had no positions in any of the securities mentioned in this column, although holdings can change at any time. Under no circumstances does the information in this commentary represent a recommendation to buy or sell stocks. She welcomes your feedback and invites you to send your comments to odette.galli@thestreet.com.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet